Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (432)

« Back to Publications

Interpreting the natural history and pathogenesis of Nipah virus disease through clinical data, to inform clinical trial design: a systematic review.

Hassan MZ. et al, (2026), Lancet Microbe, 7

Human infections with avian influenza A(H5) viruses with potential pandemic risk: 1997-2025.

Wang W. et al, (2026), Natl Sci Rev, 13

Performance of diagnostic procedures for bubonic plague in endemic settings in Madagascar: a prospective test accuracy sub-study within the IMASOY trial.

Raberahona M. et al, (2026), Clin Microbiol Infect, 32, 638 - 643

Chikungunya clinical management guidance: insights from a health system stakeholder study in Indonesia.

Sukmaningrum E. et al, (2026), BMJ Glob Health, 11

P-2000. Fast-Tracking Encephalitis Diagnosis: A Molecular Approach to Streptococcus pneumoniae and AMR Gene Detection in CSF Samples

Rahman S. et al, (2026), Open Forum Infectious Diseases, 13

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group ., (2026), Lancet Infect Dis, 26, 34 - 45

Group-Sequential Designs With an Externally-Driven Change of Primary Endpoint.

Yarahmadi A. et al, (2025), Stat Med, 44

Natural history and pathogenesis of Nipah virus disease: a systematic review of clinical data to inform clinical trial design

Horby P. et al, (2025), The Lancet Microbe

Platform Trials to Assess Therapeutics in Patients Hospitalized With Influenza.

Waite AAC. et al, (2025), J Infect Dis, 232, S254 - S261

Observational study on the clinical epidemiology of infectious acute encephalitis syndrome including Nipah virus disease, Bangladesh: BASE cohort study protocol.

Hassan MZ. et al, (2025), BMJ Open, 15

Long-term follow-up of treatment comparisons in RECOVERY: a randomised, open-label, platform trial for patients hospitalised with COVID-19

Horby PW. et al, (2025)

Molnupiravir or nirmatrelvir-ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group ., (2025), Lancet Infect Dis, 25, 1000 - 1010

Vaccine Effects on In-hospital COVID-19 Outcomes.

Gonçalves BP. et al, (2025), Epidemiology, 36, 646 - 649

WHO pandemic agreement.

Norton A. et al, (2025), BMJ, 390

Ciprofloxacin versus Aminoglycoside-Ciprofloxacin for Bubonic Plague.

Randremanana RV. et al, (2025), N Engl J Med, 393, 544 - 555

Load More

1
2
3
4
5
6
7
...
»